EP0076062B1 - Blood product storage bag - Google Patents
Blood product storage bag Download PDFInfo
- Publication number
- EP0076062B1 EP0076062B1 EP82304876A EP82304876A EP0076062B1 EP 0076062 B1 EP0076062 B1 EP 0076062B1 EP 82304876 A EP82304876 A EP 82304876A EP 82304876 A EP82304876 A EP 82304876A EP 0076062 B1 EP0076062 B1 EP 0076062B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- juncture
- closure seam
- bag according
- bag
- weakenings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
Definitions
- This invention relates generally to the field of blood component therapy and more particularly relates to containers for apparatus for the collecting, storing and dispensing of blood plasma to be processed into blood components such as albumin, globulins and so on.
- a relatively modern medical technology known as blood component therapy involves administering to a patient just that part of the blood that he actually needs. Rather than whole blood, the physician decides what portion or component of blood is necessary for the patient and administers only that component to him. He, thus, avoids many of the hazards which are inherent in whole blood usage. Not only is the practice better for the patient in that certain risks involving transfusing whole blood are reduced, but it permits one unit of donated blood to be used for more than one patient. For example, from one unit of whole blood, which subsequently is fractionated, there may be derived red blood cells, platelets, fresh plasma, frozen or stored plasma, albumin, globulins and so on.
- cell separators permit the separation of blood into its components while the donor is in the process of making a donation.
- a blood bank it is possible for a blood bank to take from the donor specific components which are needed by a patient while other components are returned simultaneously to the donor.
- the plasma is separated from the cellular elements of the blood and the cells returned to the donor.
- the plasma is then subsequently used for blood volume expansion or blood augmentation in the form of stored plasma or fresh frozen plasma.
- the plasma can also be processed into a number of useful products such as albumin, globulins and antihemophiliac factor. It is to this purpose that the present invention is directed.
- Blood is collected from the donor in a connected, sealed collection system and then centrifuged to separate the cells and the plasma.
- the cells are returned to the donor and the plasma is subsequently frozen in a collection bag.
- the plasma may be stored for a number of months before being removed for plasma component manufacturing. Subsequently, large quantities of plasma are batch processed, i.e. plasma from many donors.
- the system just described is the subject of GB-A-2,044,220.
- the blood product collection bag of that system is made of flexible material and has a body with front and rearfaces and there is a closure seam at or adjacent an end of the body. As noted above, this bag has to be cut open to free the frozen plasma, which is then ejected from the bag by squeezing the bag.
- the present practice involves receiving blood from the donor in a collection system and centrifuging it so that the plasma is collected in one of the bags of the system.
- the plasma containing bag is then separated from the rest of the collection system and is stored after freezing its contents, all prior to processing weeks or months later. Subsequently, many bags are opened, and the plasma put in a container for batch processing.
- the present invention is directed to an "easy-open" plasma bag which need not be cut to remove the plasma.
- the "easy-open" bag which holds the plasma is a sealable container of flexible material. It comprises a body so constructed that a manually applied opening force exerted thereon causes the body to rupture at predetermined locations and to tear open along predetermined lines, thus affording separation of the body from the frozen plasma without any necessity for the bag being cut by a knife or any other instrument, or for the plasma to be contacted by the hands.
- a blood product storage bag made of .flexible material and having a body with front and rear faces and a closure seam at or adjacent an end of the body, characterised by the body having an easy-open frangible construction provided by opposed weakenings, one in each of the said faces, which extend to the closure seam and are aligned with one another thereat, and stress-concentrating means which concentrate an applied opening force at the juncture of the seam and said weakenings for causing the body to rupture at the juncture and be torn open along the weakenings to separate the bag from its contents.
- the closure seam can be of V-shape configuration, the point of which intersects the juncture, the said closure seam defining a V-shape removable portion of body material on the side of the closure seam which is opposite the weakenings whereby the closure seam may be ruptured at the juncture and the body torn open along the weakenings to separate it from its contents after the V-shape body material is removed.
- the bag is provided with means which may be gripped by hand to facilitate the application of the rupturing force.
- the bag is preferably formed of a material which is capable of remaining flexible at temperatures of -25 to -80°C, e.g. of polyolefinic type.
- Fig. 1 shows a transfer bag embodying the present invention.
- the bag was used as part of multiple bag collection system and is now in an inverted position and containing frozen plasma ready for opening.
- the body 10 of the bag communicated with a donor bag (not shown) by means of a flexible tube 12, the tube now being closed by a conventional seal 14.
- the bag includes hanger holes 16 which may be employed when the donor bag is being filled.
- the bag comprises a sealable container of flexible plastics material such as polyolefin of 6 mils thickness (0.15 mm) which is capable of remaining flexible at temperatures of -25 to -80°C, i.e. the range of temperatures in which plasma is frozen and stored.
- the body 10 of the container includes a pair of weakening lines comprising frangible seams 20 or similar running from the.top to the bottom of the body (as oriented in Fig. 1).
- the seams join one another at a juncture 22.
- the lines 20 will be seen to be located at opposite sides of the body 10 and in a plane bisecting the body.
- a closure seam 24 Transversely intersecting the juncture 22 of the frangible lines 20 is a closure seam 24 which is of greater width than the width of the frangible seams.
- a pair of ears 26 lie laterally of the juncture 22 to one side of (in this instance above) the closure seam 24, opposite the frangible lines 20.
- the edges of the ears 26 are rounded and converge toward the juncture 22.
- the closure seam 24 is essentially along a straight line, sealing the top of the bag and separating the interior of the body from the ears 26.
- ribs 28 are formed in the body and extend from the closure seam 24 in diverging directions away from the juncture 22 to the edges of the body 10.
- the ribs 28 define portions 30 of the body lying laterally of the juncture which are sealed from the interior of the body and accordingly contain no plasma.
- the ears 26 alone or together with the closure seam 24 and/or the portions 30 are gripped and pulled apart either as shown in Fig. 2 or in Fig. 3, thereby directing or concentrating force at the juncture 22.
- the bag ruptures at the juncture 22 permitting the body 10 to be torn apart along the frangible lines 20 whereby the flexible plastics film may be peeled away from the frozen plasma within the bag and the plasma allowed to fall into a collection container without being touched by a knife or other opening instrument, or by the hands.
- the bag of course would be inverted from the positions shown in Figs. 1, 2 and 3 for releasing its contents. While Figs. 2 and 3 show the flexible container being torn apart by bare hands, some may prefer to wear gloves as insulation from the cold contents.
- opening required the bag to be cut open with a knife to expose the plasma as well as thawing of its contents slightly from the outside inwardly to release the frozen plasma from the inner surface of the bag. Because of the construction of the present invention, the bag need not be cut. Since the bag is essentially peeled back away from the frozen plasma, there is no skin thawing necessary preparatory to opening the bag.
- Fig. 4. shows an alternative construction of the openable portion of the bag.
- the closure seam 24, as in the Fig. 1 construction, is essentially a straight line running across top of the bag intersecting the juncture with the frangible lines 20.
- the closure seam 24 has a notch 34 aligned with the juncture 22 to concentrate rupturing force at the juncture 22.
- FIG. 5 Another alternative construction of the body is shown in Fig. 5.
- the closure seam 24 is of V-shape configuration comprising portions 24a and 24b converging toward the juncture 22.
- Ribs 28 define areas 30 equivalent to the portions 30 in the Fig. 1 construction. Again, the ribs 28 and unfilled areas 30 are optional. However, since there are no ears, it would be the closure seam portions 24a and 24b (with the portions 30 if provided) that would be gripped and pulled apart.
- the V-shape configuration of the seam 24 concentrates the applied force at the juncture 22 to initiate tearing of the frangible lines 20.
- Figs. 6 and 7 show another alternative construction.
- the closure seam 24 as in the Fig. 5 construction is of V-shape configuration converging at the juncture with the frangible seams 20.
- the ribs 28a and 28b also converge at the juncture and as described above define unfilled areas 30.
- the ribs 28a and 28b converge at the juncture.
- the closure seam portions 24a and the rib 28a are aligned linear extensions of each other as are the seam portion 24b and the rib 28b.
- the triangular portion 40 remains attached to the bag until it is ready to be opened. It will be noted in Fig. 6 that a line of serrations 46 extend along the closure seam portions 24a and 24b. The provision of the triangular portion 40 lends additional strength to the bag to guarantee against premature rupture at the juncture 22.
- the portion 40 is torn from the bag along the lines of serration 46 rendering the bag as it appears in Fig. 7. Thereafter, the portions 30 and/or the closure seam portions 24a and 24b may be gripped and pulled apart to develop and concentrate rupturing force at the juncture 22 as in above described constructions.
- the various constructions may be fabricated in various ways. They may be made by cutting off blanks from a continuous tube of polyolefin material and forming the frangible lines 20, the bottom 36, the closure seam 24, and the ribs 28 by heat sealing. Another method of fabrication would be to start with sheet material folded upon itself with the various ribs, seams and lines also formed by heat sealing.
- Another method would be by forming the entire bag by blow molding.
- the various ribs, seams and lines would be formed in the mold cavity and imparted to the bag in the blow molding process.
Abstract
Description
- This invention relates generally to the field of blood component therapy and more particularly relates to containers for apparatus for the collecting, storing and dispensing of blood plasma to be processed into blood components such as albumin, globulins and so on.
- A relatively modern medical technology known as blood component therapy involves administering to a patient just that part of the blood that he actually needs. Rather than whole blood, the physician decides what portion or component of blood is necessary for the patient and administers only that component to him. He, thus, avoids many of the hazards which are inherent in whole blood usage. Not only is the practice better for the patient in that certain risks involving transfusing whole blood are reduced, but it permits one unit of donated blood to be used for more than one patient. For example, from one unit of whole blood, which subsequently is fractionated, there may be derived red blood cells, platelets, fresh plasma, frozen or stored plasma, albumin, globulins and so on.
- Furthermore, in the most modern techniques, cell separators permit the separation of blood into its components while the donor is in the process of making a donation. Through modern technology it is possible for a blood bank to take from the donor specific components which are needed by a patient while other components are returned simultaneously to the donor.
- In the technique known as plasmapheresis, the plasma is separated from the cellular elements of the blood and the cells returned to the donor. The plasma is then subsequently used for blood volume expansion or blood augmentation in the form of stored plasma or fresh frozen plasma. The plasma can also be processed into a number of useful products such as albumin, globulins and antihemophiliac factor. It is to this purpose that the present invention is directed.
- Blood is collected from the donor in a connected, sealed collection system and then centrifuged to separate the cells and the plasma. The cells are returned to the donor and the plasma is subsequently frozen in a collection bag. In the frozen state the plasma may be stored for a number of months before being removed for plasma component manufacturing. Subsequently, large quantities of plasma are batch processed, i.e. plasma from many donors.
- During this batch processing contamination is an obvious risk. The whole blood is initially collected in a sealed system which is followed by centrifuging and freezing while still sealed. However, the bags must ultimately be cut open and the plasma removed either manually or automatically. It is possible that during the opening and removing operation the plasma can become contaminated.
- The system just described is the subject of GB-A-2,044,220. The blood product collection bag of that system is made of flexible material and has a body with front and rearfaces and there is a closure seam at or adjacent an end of the body. As noted above, this bag has to be cut open to free the frozen plasma, which is then ejected from the bag by squeezing the bag.
- The present practice involves receiving blood from the donor in a collection system and centrifuging it so that the plasma is collected in one of the bags of the system. The plasma containing bag is then separated from the rest of the collection system and is stored after freezing its contents, all prior to processing weeks or months later. Subsequently, many bags are opened, and the plasma put in a container for batch processing. The present invention is directed to an "easy-open" plasma bag which need not be cut to remove the plasma.
- Whilst easy-open packaging such as bags and other containers are known for containing various products, see for example US-A-3,259,235, US-A-3,516,537 and US-A-3,604,616, so far as we know no-one hitherto has devised an easy-open arrangement suiting the requirements of a blood product storage bag.
- The "easy-open" bag which holds the plasma is a sealable container of flexible material. It comprises a body so constructed that a manually applied opening force exerted thereon causes the body to rupture at predetermined locations and to tear open along predetermined lines, thus affording separation of the body from the frozen plasma without any necessity for the bag being cut by a knife or any other instrument, or for the plasma to be contacted by the hands.
- According to the present invention, there is provided a blood product storage bag made of .flexible material and having a body with front and rear faces and a closure seam at or adjacent an end of the body, characterised by the body having an easy-open frangible construction provided by opposed weakenings, one in each of the said faces, which extend to the closure seam and are aligned with one another thereat, and stress-concentrating means which concentrate an applied opening force at the juncture of the seam and said weakenings for causing the body to rupture at the juncture and be torn open along the weakenings to separate the bag from its contents.
- The closure seam can be of V-shape configuration, the point of which intersects the juncture, the said closure seam defining a V-shape removable portion of body material on the side of the closure seam which is opposite the weakenings whereby the closure seam may be ruptured at the juncture and the body torn open along the weakenings to separate it from its contents after the V-shape body material is removed.
- Preferably, the bag is provided with means which may be gripped by hand to facilitate the application of the rupturing force. Moreover, the bag is preferably formed of a material which is capable of remaining flexible at temperatures of -25 to -80°C, e.g. of polyolefinic type.
- The present invention will now be more particularly described with reference to the accompanying drawings in which containers embodying the invention are shown by way of exemplary illustration only. The principles of this invention may be employed in other embodiments without departing from the scope of the appended claims. In the drawings:
- Fig. 1 is a perspective view of an "easy-open" sealable container or bag of flexible material embodying the invention;
- Figs. 2 and 3 are views of the bag shown in Fig. 1 being opened;
- Figs. 4 and 5 are views of alternative bag constructions according to the invention; and
- Figs. 6 and 7 are views of another alternative bag construction according to the invention.
- Fig. 1 shows a transfer bag embodying the present invention. The bag was used as part of multiple bag collection system and is now in an inverted position and containing frozen plasma ready for opening. The
body 10 of the bag communicated with a donor bag (not shown) by means of aflexible tube 12, the tube now being closed by aconventional seal 14. The bag includes hanger holes 16 which may be employed when the donor bag is being filled. The bag comprises a sealable container of flexible plastics material such as polyolefin of 6 mils thickness (0.15 mm) which is capable of remaining flexible at temperatures of -25 to -80°C, i.e. the range of temperatures in which plasma is frozen and stored. - Depending on its method of manufacture, the
body 10 of the container includes a pair of weakening lines comprisingfrangible seams 20 or similar running from the.top to the bottom of the body (as oriented in Fig. 1). The seams join one another at ajuncture 22. - As viewed in Figs. 2 and 3 (which is a view only slightly in perspective of the openable end of the bag), the
lines 20 will be seen to be located at opposite sides of thebody 10 and in a plane bisecting the body. Transversely intersecting thejuncture 22 of thefrangible lines 20 is aclosure seam 24 which is of greater width than the width of the frangible seams. In the construction shown in Figs. 1, 2 and 3 a pair ofears 26 lie laterally of thejuncture 22 to one side of (in this instance above) theclosure seam 24, opposite thefrangible lines 20. The edges of theears 26 are rounded and converge toward thejuncture 22. Theclosure seam 24 is essentially along a straight line, sealing the top of the bag and separating the interior of the body from theears 26. - Also as seen in Figs. 1 and 2 (but hidden in Fig. 3)
ribs 28 are formed in the body and extend from theclosure seam 24 in diverging directions away from thejuncture 22 to the edges of thebody 10. Theribs 28 defineportions 30 of the body lying laterally of the juncture which are sealed from the interior of the body and accordingly contain no plasma. - To open the body, the
ears 26 alone or together with theclosure seam 24 and/or theportions 30 are gripped and pulled apart either as shown in Fig. 2 or in Fig. 3, thereby directing or concentrating force at thejuncture 22. The bag ruptures at thejuncture 22 permitting thebody 10 to be torn apart along thefrangible lines 20 whereby the flexible plastics film may be peeled away from the frozen plasma within the bag and the plasma allowed to fall into a collection container without being touched by a knife or other opening instrument, or by the hands. The bag of course would be inverted from the positions shown in Figs. 1, 2 and 3 for releasing its contents. While Figs. 2 and 3 show the flexible container being torn apart by bare hands, some may prefer to wear gloves as insulation from the cold contents. - In some prior plasma bag constructions, opening required the bag to be cut open with a knife to expose the plasma as well as thawing of its contents slightly from the outside inwardly to release the frozen plasma from the inner surface of the bag. Because of the construction of the present invention, the bag need not be cut. Since the bag is essentially peeled back away from the frozen plasma, there is no skin thawing necessary preparatory to opening the bag.
- Fig. 4.shows an alternative construction of the openable portion of the bag. The
closure seam 24, as in the Fig. 1 construction, is essentially a straight line running across top of the bag intersecting the juncture with thefrangible lines 20. Theclosure seam 24 has anotch 34 aligned with thejuncture 22 to concentrate rupturing force at thejuncture 22. There are noears 26 on the body and it would be optional to provideribs 28 defining the sealedportions 30 containing no plasma. - Another alternative construction of the body is shown in Fig. 5. In this alternative the
closure seam 24 is of V-shapeconfiguration comprising portions juncture 22.Ribs 28 defineareas 30 equivalent to theportions 30 in the Fig. 1 construction. Again, theribs 28 andunfilled areas 30 are optional. However, since there are no ears, it would be theclosure seam portions portions 30 if provided) that would be gripped and pulled apart. The V-shape configuration of theseam 24 concentrates the applied force at thejuncture 22 to initiate tearing of thefrangible lines 20. - Figs. 6 and 7 show another alternative construction. The
closure seam 24 as in the Fig. 5 construction is of V-shape configuration converging at the juncture with the frangible seams 20. Theribs unfilled areas 30. - For ease of construction, the
ribs closure seam portions 24a and therib 28a are aligned linear extensions of each other as are theseam portion 24b and therib 28b. By this configuration, there is a substantiallytriangular portion 40 on the side of theclosure seam 24a-24b opposite theareas 30 which is made up of the folded overlapping corners of the bag material designated 42. These are secured together by a combiningseam 44. - The
triangular portion 40 remains attached to the bag until it is ready to be opened. It will be noted in Fig. 6 that a line ofserrations 46 extend along theclosure seam portions triangular portion 40 lends additional strength to the bag to guarantee against premature rupture at thejuncture 22. - When the bag is ready to be opened, the
portion 40 is torn from the bag along the lines ofserration 46 rendering the bag as it appears in Fig. 7. Thereafter, theportions 30 and/or theclosure seam portions juncture 22 as in above described constructions. - The various constructions may be fabricated in various ways. They may be made by cutting off blanks from a continuous tube of polyolefin material and forming the
frangible lines 20, the bottom 36, theclosure seam 24, and theribs 28 by heat sealing. Another method of fabrication would be to start with sheet material folded upon itself with the various ribs, seams and lines also formed by heat sealing. - Another method would be by forming the entire bag by blow molding. The various ribs, seams and lines would be formed in the mold cavity and imparted to the bag in the blow molding process.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT82304876T ATE20821T1 (en) | 1981-09-25 | 1982-09-16 | CONTAINERS FOR STORING BLOOD COMPONENTS. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30549081A | 1981-09-25 | 1981-09-25 | |
US305490 | 2002-11-26 |
Publications (4)
Publication Number | Publication Date |
---|---|
EP0076062A2 EP0076062A2 (en) | 1983-04-06 |
EP0076062A3 EP0076062A3 (en) | 1984-03-28 |
EP0076062B1 true EP0076062B1 (en) | 1986-07-23 |
EP0076062B2 EP0076062B2 (en) | 1989-12-27 |
Family
ID=23181023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP82304876A Expired EP0076062B2 (en) | 1981-09-25 | 1982-09-16 | Blood product storage bag |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0076062B2 (en) |
JP (1) | JPS5864953A (en) |
AT (1) | ATE20821T1 (en) |
AU (1) | AU8756582A (en) |
DE (1) | DE3272155D1 (en) |
DK (1) | DK426382A (en) |
ES (1) | ES276158Y (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2133383A (en) * | 1983-01-14 | 1984-07-25 | Scottish Health Service Common | Plasma bags |
EP0159792A3 (en) * | 1984-03-16 | 1986-11-20 | Tuta Laboratories (Australia) Pty Ltd. | Bag stripping machine |
GB2161453B (en) * | 1984-07-13 | 1989-05-17 | Tuta Lab | Plasma bags |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE533018A (en) * | ||||
US3051368A (en) * | 1958-11-28 | 1962-08-28 | Schneider | Dispensing container |
US3412918A (en) * | 1966-10-31 | 1968-11-26 | Phillips Petroleum Co | Dispensing container |
JPS4813052U (en) * | 1971-06-25 | 1973-02-14 | ||
US3913789A (en) * | 1974-02-13 | 1975-10-21 | United States Banknote Corp | Fluid container of the flexible wall capsule type |
US4253458A (en) * | 1979-03-08 | 1981-03-03 | Baxter Travenol Laboratories, Inc. | Method and apparatus for collecting blood plasma |
JPS55158844U (en) * | 1979-05-02 | 1980-11-14 | ||
JPS5943225Y2 (en) * | 1980-11-10 | 1984-12-20 | 株式会社生産日本社 | Synthetic resin bag |
FR2495583A1 (en) * | 1980-12-09 | 1982-06-11 | Boncolac Sa | Individual packing for ice cream - is of conical form and is opened by tearing from base point along tear lines |
-
1982
- 1982-08-24 AU AU87565/82A patent/AU8756582A/en not_active Abandoned
- 1982-09-16 EP EP82304876A patent/EP0076062B2/en not_active Expired
- 1982-09-16 DE DE8282304876T patent/DE3272155D1/en not_active Expired
- 1982-09-16 AT AT82304876T patent/ATE20821T1/en not_active IP Right Cessation
- 1982-09-24 ES ES1982276158U patent/ES276158Y/en not_active Expired
- 1982-09-24 JP JP57166428A patent/JPS5864953A/en active Granted
- 1982-09-24 DK DK426382A patent/DK426382A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK426382A (en) | 1983-03-26 |
JPS5864953A (en) | 1983-04-18 |
EP0076062B2 (en) | 1989-12-27 |
DE3272155D1 (en) | 1986-08-28 |
AU8756582A (en) | 1983-03-31 |
ATE20821T1 (en) | 1986-08-15 |
ES276158Y (en) | 1985-03-01 |
JPH0563381B2 (en) | 1993-09-10 |
EP0076062A3 (en) | 1984-03-28 |
ES276158U (en) | 1984-08-01 |
EP0076062A2 (en) | 1983-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4480751A (en) | Apparatus for collecting, storing and dispensing frozen blood plasma | |
US5306269A (en) | Bottom blood bag separation system | |
US4116338A (en) | Package for sterile article | |
US5033868A (en) | Flexible plastic bag with perforated handle | |
US5770051A (en) | Apparatus for separating blood in an integrally formed container | |
US4198972A (en) | Blood and blood component storage bags | |
US4253458A (en) | Method and apparatus for collecting blood plasma | |
US3862684A (en) | Aseptic packing container and method of making and filling it | |
CA1311449C (en) | Flexible thermoplastic pouches having easy-open tear strip means and apparatus for making same | |
US5253754A (en) | Peel package and method of packaging organs | |
US5897052A (en) | Easily laterally opened type paper container | |
US3674195A (en) | Filled and sealed easily opened bag and method of making same | |
US5971971A (en) | Pouch for packaging biologic liquid substances with peelable opening for insertion of cannulae, tubes and probes | |
JPH06511452A (en) | Bag-like packaging of cylindrical film, especially for sanitary towels and similar items | |
US4715528A (en) | Reclosable opening arrangement on a packing container | |
US4190154A (en) | Sterile package | |
CA1128004A (en) | Peelable seal | |
EP0076062B1 (en) | Blood product storage bag | |
US3254829A (en) | Sealing of thermoplastic containers | |
JP5101054B2 (en) | Easy-open packaging | |
JPS6240926Y2 (en) | ||
JPH0427808Y2 (en) | ||
GB2131384A (en) | Packaging for surgical apparatus | |
JPH0262257B2 (en) | ||
JPH08187282A (en) | Blood bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): AT CH DE FR GB IT LI NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Designated state(s): AT CH DE FR GB IT LI NL SE |
|
17P | Request for examination filed |
Effective date: 19840502 |
|
ITF | It: translation for a ep patent filed |
Owner name: BARZANO' E ZANARDO MILANO S.P.A. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT CH DE FR GB IT LI NL SE |
|
REF | Corresponds to: |
Ref document number: 20821 Country of ref document: AT Date of ref document: 19860815 Kind code of ref document: T |
|
ET | Fr: translation filed | ||
REF | Corresponds to: |
Ref document number: 3272155 Country of ref document: DE Date of ref document: 19860828 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 19860930 Year of fee payment: 5 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
26 | Opposition filed |
Opponent name: BIOTEST PHARMA GMBH Effective date: 19870410 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: BIOTEST PHARMA GMBH |
|
26 | Opposition filed |
Opponent name: FISONS PLC Effective date: 19870417 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: FISONS PLC |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19870930 Year of fee payment: 6 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: LATHAM LABS. INC. |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: HAEMONETICS CORPORATION(A MASSACHUSETTS CORPORATIO |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: LATHAM LABS. INC. TE BRAINTREE, MASSACHUSETTS, VER |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Effective date: 19880916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19880917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19880930 Ref country code: CH Effective date: 19880930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19890401 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
ITF | It: translation for a ep patent filed |
Owner name: BARZANO' E ZANARDO MILANO S.P.A. |
|
PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
27A | Patent maintained in amended form |
Effective date: 19891227 |
|
AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): AT CH DE FR GB IT LI NL SE |
|
ET3 | Fr: translation filed ** decision concerning opposition | ||
EUG | Se: european patent has lapsed |
Ref document number: 82304876.4 Effective date: 19890712 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20001130 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20001201 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20001211 Year of fee payment: 19 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010916 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020501 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20010916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020531 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |